Found 13 matching trials
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis PHASE4 Background:
* Rheumatoid arthritis (RA) is often treated with drugs known ...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis PHASE3 Demonstrate equivalent efficacy of GP2015 and EU-authorized Enbrel in patie...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA PHASE4 This study involves Rheumatoid Arthritis patients in regular clinical setti...
Show More Location
Pfizer Investigational Site
Learn More & Join Trial
REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST) PHASE4 Participants maintaining stable disease activity of Ankylosing Spondylitis ...
Show More Location
Multiple Locations
Learn More & Join Trial
A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (RA) PHASE2 The purpose of this study is to confirm that AZD9056 is effective in treati...
Show More Learn More & Join Trial
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis PHASE2 The study has been designed with three components. Part A is an open label ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) PHASE3 The purpose of this study is to investigate the efficacy and safety of two ...
Show More Learn More & Join Trial
Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects PHASE1 The purpose of this study is compare the safety and pharmacokinetic charact...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011) PHASE3 This study is being conducted to evaluate the efficacy and safety/tolerabil...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo. PHASE3 This withdrawn study was to assess the safety and efficacy of secukinumab c...
Show More Location
Multiple Locations
Learn More & Join Trial